CA
TMDX icon

Clearstead Advisors’s Transmedics TMDX Stock Holding History

Clearstead Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Buy
152
+2
+1% +$169 ﹤0.01% 1972
2026
Q1 		$14.9K Sell
150
-32
-18% -$4.17K ﹤0.01% 1509
2025
Q4 		$22.1K Hold
182
– – ﹤0.01% 1680
2025
Q3 		$20.4K Sell
182
-14
-7% -$1.64K ﹤0.01% 1638
2025
Q2 		$26.3K Buy
196
+24
+14% +$2.63K ﹤0.01% 1510
2025
Q1 		$11.6K Buy
172
+22
+15% +$1.51K ﹤0.01% 1574
2024
Q4 		$9.35K Sell
150
-87
-37% -$8.1K ﹤0.01% 1589
2024
Q3 		$37.2K Hold
237
– – ﹤0.01% 1271
2024
Q2 		$35.7K Buy
237
+87
+58% +$10.4K ﹤0.01% 1244
2024
Q1 		$19.8K Hold
150
– – ﹤0.01% 948
2023
Q4 		$11.8K Hold
150
– – ﹤0.01% 1031
2023
Q3 		$8.21K Hold
150
– – ﹤0.01% 1021
2023
Q2 		$12.6K Hold
150
– – ﹤0.01% 956
2023
Q1 		$11.4K Hold
150
– – ﹤0.01% 933
2022
Q4 		$9.26K Hold
150
– – ﹤0.01% 911
2022
Q3 		$6K Hold
150
– – ﹤0.01% 961
2022
Q2 		$5K Hold
150
– – ﹤0.01% 1012
2022
Q1 		$4K Hold
150
– – ﹤0.01% 1120
2021
Q4 		$3K Hold
150
– – ﹤0.01% 1078
2021
Q3 		$5K Hold
150
– – ﹤0.01% 1037
2021
Q2 		$5K Hold
150
– – ﹤0.01% 894
2021
Q1 		$6K Buy
+150
New +$4.62K ﹤0.01% 855

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Clearstead Advisors's TMDX Position: Q2 2026 in Review

Clearstead Advisors increased its Transmedics (TMDX) stake by 1.3% in Q2 2026, buying an estimated $169 and bringing the position to 152 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

Clearstead Advisors first reported a position in TMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $37.2K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Clearstead Advisors held 152 shares of Transmedics worth $10.1K as of Q2 2026.
  • Clearstead Advisors bought 2 Transmedics shares in Q2 2026, an estimated $169.
  • Transmedics made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1972 holding.
  • Clearstead Advisors first reported a position in Transmedics in Q1 2021 and has held it in 22 quarters since.
  • Clearstead Advisors's Transmedics position peaked at $37.2K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.